TAMPA, Fla. (Oct. 21, 2013) – Brian C. Springer, M.H.A., has joined Moffitt Cancer Center as the new vice president of Research Administration and associate center director of Administration. Springer will work closely with executive leadership, faculty and team members to enhance and cultivate the cancer center’s world-class research. He will also oversee external funding, as well as the renewal of Moffitt’s National Cancer Institute Cancer Center Support Grant.
Moffitt is Florida’s leading cancer hospital and research institute. The center received more than $55 million in grant funding in 2012. It has also filed 250 original patent applications and obtained 100 licenses for further development and commercialization since opening in 1986.
“To ensure that our scientists are successful in finding novel ways to prevent and cure cancer, we need to provide outstanding infrastructure and support so that they can focus on their research. Brian brings great experience, insight, and innovative approaches to ensure we do just that,” said Thomas A. Sellers, Ph.D., M.P.H, Moffitt’s center director and executive vice president.
Springer previously was the executive vice president at Roswell Park Cancer Institute in Buffalo, N.Y., where he oversaw the fiscal and managerial administration of all operations with a staff of 3,300 and an operating budget of $600 million. He also held senior administrative leadership positions at two other National Cancer Institute-designated Comprehensive Cancer Centers: executive director at the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis and assistant director of finance and administration and director of clinical research management at the Comprehensive Cancer Center of Wake Forest University in Winston-Salem, N.C.
Springer received his Master of Healthcare Administration degree from The University of North Carolina at Chapel Hill. He is a member of the Cancer Center Administrators Forum and chairs its Information Technology Steering Committee; he is also a member of the National Comprehensive Cancer Network and Association of American Cancer Institutes.
The NCI Cancer Center Support Grant that Springer will oversee was approved for another five years in 2012. The grant supports the research infrastructure at Moffitt, which consists of five research programs – Cancer Biology and Evolution; Cancer Epidemiology; Chemical Biology and Molecular Medicine; Health Outcomes and Behavior; and Immunology. Each program is made up of a multidisciplinary team that focuses on an overall scientific theme and specific aim, which together provide Moffitt’s strong, multidimensional approach to defeating cancer.
About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the No. 1 cancer hospital in Florida and has been listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer since 1999. With more than 4,200 employees, Moffitt has an economic impact on the state of nearly $2 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.